THRIVE Monthly

$90.00 / month

Anresco Labs COA** FMCTHR0220

Ratio CBD:THC: 1:1
Dosage: 5mg CBD and 5mg THC (each capsule)
Packaging: Pill Cards of 30 capsules, each that contain a total of 300mg of combined cannabinoids.

Ideal for: Patients seeking a balance between physical comfort and mental relaxation.

* Product prices do not include all taxes, fees & delivery

Category:

Description

THRIVE – CBD:THC 1:1

Widely recommended for: people living with dementia, to ease symptoms of agitation, aggression, restlessness, anorexia, depression; patients suffering with insomnia; pain; fighting cancer; improving symptoms related to muscle stiffness (spasticity) in multiple sclerosis (MS); reducing tremors and rigidity; elevating mood and creating a general sense of wellbeing. There is an equal amount of 5mgs CBD to 5mgs THC in Thrive.

OUR CAPSULES (CAPS) each contain a specific, consistent cannabinoid dosage including a proprietary balance of natural terpene extracts. Capsules are then packaged, labeled and batch tested for accuracy, potency and potential contaminants. Delivery consists of a child-resistant zip bag containing a pharmacy style blister Pill Card, including patient-specific labels.

Whether you are a doctor, caregiver, care facility director or patient, you can be confident Farmacann products always meet or exceed the manufacturing, testing and regulatory requirements of the State of California, Medical Professionals and Licensed Care Facilities and every batch of each product receives a COA** from Anresco Laboratories in San Francisco, an industry leader since 1943, ISO 17025 accredited, FDA registered, and ELAP certified.

** A Certificate of Analysis, or COA, is a document issued by a third-party, independent testing laboratory that confirms a product meets its specification, including quantity of cannabinoids and terpenes found in each product as well as confirming that each product does not contain harmful heavy metals, pesticides, solvents, and pathogens.